Seema Dangwal

Dr. Seema Dangwal

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ATAna Tellechea
Ana Tellechea
SBSha Bai
Sha Bai
SDSeema Dangwal
Seema Dangwal
GTGeorgios Theocharidis
Georgios Theocharidis
MNMasa Nagai
Masa Nagai
AVAristidis Veves
Aristidis Veves

29 September 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
ACAylin Caliskan
Aylin Caliskan
SCSamantha A. W. Crouch
Samantha A. W. Crouch
SGSARA GIDDINS
SARA GIDDINS
Thomas DandekarThomas Dandekar
Thomas Dandekar
SDSeema Dangwal
Seema Dangwal
Since ancient times aging has also been regarded as a disease, and humankind has always strived to extend the natural lifespan. Analyzing the genes involved in aging and disease allows for finding important indicators and biological markers for pathologies and possible therapeutic targets. An example of the use of omics technologies is the research regarding aging and the rare and fatal premature aging syndrome progeria (Hutchinson-Gilford progeria syndrome, HGPS). In our study, we focused on the in silico analysis of differentially expressed genes (DEGs) in progeria and aging, using a publicly available RNA-Seq dataset (GEO dataset GSE113957) and a variety of bioinformatics tools. Despite the GSE113957 RNA-Seq dataset being well-known and frequently analyzed, the RNA-Seq data shared by Fleischer et al. is far from exhausted and reusing and repurposing the data still reveals new insights. By analyzing the literature citing the use of the dataset and subsequently conducting a comparative analysis comparing the RNA-Seq data analyses of different subsets of the dataset (healthy children, nonagenarians and progeria patients), we identified several genes involved in both natural aging and progeria (KRT8, KRT18, ACKR4, CCL2, UCP2, ADAMTS15, ACTN4P1, WNT16, IGFBP2). Further analyzing these genes and the pathways involved indicated their possible roles in aging, suggesting the need for further in vitro and in vivo research. In this paper, we (1) compare “normal aging” (nonagenarians vs. healthy children) and progeria (HGPS patients vs. healthy children), (2) enlist genes possibly involved in both the natural aging process and progeria, including the first mention of IGFBP2 in progeria, (3) predict miRNAs and interactomes for WNT16 (hsa-mir-181a-5p), UCP2 (hsa-mir-26a-5p and hsa-mir-124-3p), and IGFBP2 (hsa-mir-124-3p, hsa-mir-126-3p, and hsa-mir-27b-3p), (4) demonstrate the compatibility of well-established R packages for RNA-Seq analysis for researchers interested but not yet familiar with this kind of analysis, and (5) present comparative proteomics analyses to show an association between our RNA-Seq data analyses and corresponding changes in protein expression.

Verified
Journal Article
Open access
PDF file
SGShishir Kumar Gupta
Shishir Kumar Gupta
Mugdha SrivastavaMugdha Srivastava
Mugdha Srivastava
RMRashmi Minocha
Rashmi Minocha
AAAman Akash
Aman Akash
SDSeema Dangwal
Seema Dangwal
Thomas DandekarThomas Dandekar
Thomas Dandekar
A viral infection involves entry and replication of viral nucleic acid in a host organism, subsequently leading to biochemical and structural alterations in the host cell. In the case of SARS-CoV-2 viral infection, over-activation of the host immune system may lead to lung damage. Albeit the regeneration and fibrotic repair processes being the two protective host responses, prolonged injury may lead to excessive fibrosis, a pathological state that can result in lung collapse. In this review, we discuss regeneration and fibrosis processes in response to SARS-CoV-2 and provide our viewpoint on the triggering of alveolar regeneration in coronavirus disease 2019 (COVID-19) patients.

10 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
MSMichael Simeon
Michael Simeon
SDSeema Dangwal
Seema Dangwal
Agapios SachinidisAgapios Sachinidis
Agapios Sachinidis
MJMichael Xavier Doss Jesudoss
Michael Xavier Doss Jesudoss
Personalized regenerative medicine and biomedical research have been galvanized and revolutionized by human pluripotent stem cells in combination with recent advances in genomics, artificial intelligence, and genome engineering. More recently, we have witnessed the unprecedented breakthrough life-saving translation of mRNA-based vaccines for COVID-19 to contain the global pandemic and the investment in billions of US dollars in space exploration projects and the blooming space-tourism industry fueled by the latest reusable space vessels. Now, it is time to examine where the translation of pluripotent stem cell research stands currently, which has been touted for more than the last two decades to cure and treat millions of patients with severe debilitating degenerative diseases and tissue injuries. This review attempts to highlight the accomplishments of pluripotent stem cell research together with cutting-edge genomics and genome editing tools and, also, the promises that have still not been transformed into clinical applications, with cardiovascular research as a case example. This review also brings to our attention the scientific and socioeconomic challenges that need to be effectively addressed to see the full potential of pluripotent stem cells at the clinical bedside.

2 January 2023
Verified
Book Chapter
Closed access
PDF file
ACAylin Caliskan
Aylin Caliskan
SCSamantha A. W. Crouch
Samantha A. W. Crouch
SDSeema Dangwal
Seema Dangwal

16 December 2021
Verified
Book Chapter
Closed access
PDF file
HSHitesh Soni
Hitesh Soni
SDSeema Dangwal
Seema Dangwal